In a bid to expand its international presence, Biogen Idec has announced it’s restarting construction of its large-scale biologic manufacturing facility in Hillerod, Denmark.
International Construction
ZUG, SWITZERLAND
In a bid to expand its international presence, Biogen Idec has announced it’s restarting construction of its large-scale biologic manufacturing facility in Hillerod, Denmark.
Biogen Idec expects to invest $340 million (U.S.) to build the facility, which will generate approximately 200 jobs. The facility is expected to be available for commercial production in 2008.
Biogen Idec is a global leader in the development, manufacturing and commercialization of novel therapies in oncology and immunology. It’s known for transforming scientific discoveries into advances in human healthcare.
Biogen Idec has a huge international presence with operations in Australia, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Luxembourg, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, the United Kingdom and Canada.
—DCN staff
Recent Comments
comments for this post are closed